Tenderwize
Back to tender search

Open-house rebate agreement for testosterone injection solution

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Nov 03, 2027 · 443 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Testosteron in der Darreichungsform Injektionslösung, ATC G03BA03

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

The notice repeatedly states that the arrangement is an open-house model and not a normal procurement procedure, which...

Paper submissions must be sent in duplicate originals, and electronic submissions must use the DTVP communication area...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Dec 2027
  • Non-exclusive rebate agreements for pharmaceutical products concerning testosterone in injection solution form, ATC G03BA03.
  • Open-house model with identical, non-negotiable contract terms for all qualifying pharmaceutical companies.
Show full summary

This is an open-house pharmaceutical supply arrangement by AOK Bayern for testosterone injection solution (ATC G03BA03), not a competitive award procedure in the usual sense. The buyer states that it will conclude identical, non-exclusive rebate agreements with all interested pharmaceutical companies that meet the stated suitability requirement. Contracting is possible from 2026-01-01 until 2027-11-03, with contracts ending on 2027-12-31. Submission is via DTVP electronic portal with qualified electronic signature or by signed paper originals in duplicate; German language is required, and non-German documents need German translation.

Risks

The notice repeatedly states that the arrangement is an open-house model and not a normal procurement procedure, which...

Paper submissions must be sent in duplicate originals, and electronic submissions must use the DTVP communication area...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.
  • The signed contract and the completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be submitted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for testosterone injection solution

Single lot covering non-exclusive open-house rebate agreements for the medicinal product testosterone in injection solution form, ATC G03BA03. The notice says the contract terms are fixed and not individually negotiable. Place of performance is Germany, Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Dec 2025 - Dec 2027

Category

Pharmaceutical products

Deadline

Deadline Nov 03, 2027

Procurement Details

Publication date
16 Nov 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
759950-2025

Documents (2)

Similar tenders